Health Care & Life Sciences » Biotechnology | Fibrocell Science Inc.

Fibrocell Science Inc.

Fibrocell Science Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.41
Market Cap
$18.54 M
Shares Outstanding
9.76 M
Public Float
8.1 M

Profile

Address
405 Eagleview Boulevard
Exton Pennsylvania 19341
United States
Employees -
Website http://www.fibrocell.com
Updated 07/08/2019
Fibrocell Science, Inc. is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA.

Financials

View All
Created with Highcharts 5.0.14Fibrocell Science Inc.Net Income. Fiscal year is January-December. All values USD Thousands.31 55431 55425 65025 65034 45334 45315 29215 29216 24016 24010 27710 277201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Fibrocell Science Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.200200180180492492355355003923922013201420152016201720180100200300400500600

John M. Maslowski
President, CEO, CFO & Director
Marcus E. Smith
Non-Executive Director